Sign Up to like & get
recommendations!
0
Published in 2024 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2024.42.16_suppl.e21545
Abstract: e21545 Background: NRAS mutant melanoma is an aggressive subtype making up 20-30% of cutaneous melanoma cases without specific treatment options beyond immune checkpoint inhibition (ICI). Previous studies have suggested specific NRAS codon mutations are associated…
read more here.
Keywords:
codon specific;
codon;
melanoma;
cutaneous melanoma ... See more keywords